Citadel Advisors’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,823,272
Closed -$268M 10212
2018
Q3
$268M Sell
2,823,272
-422,199
-13% -$36M 0.12% 115
2018
Q2
$251M Buy
3,245,471
+1,467,456
+83% +$110M 0.12% 107
2018
Q1
$123M Buy
1,778,015
+450,248
+34% +$34.4M 0.07% 248
2017
Q4
$99.1M Sell
1,327,767
-468,666
-26% -$30M 0.06% 332
2017
Q3
$114M Buy
1,796,433
+43,738
+2% +$2.72M 0.09% 214
2017
Q2
$112M Sell
1,752,695
-196,113
-10% -$12.3M 0.09% 194
2017
Q1
$128M Buy
1,948,808
+1,529,364
+365% +$105M 0.12% 141
2016
Q4
$28.9M Buy
419,444
+50,809
+14% +$3.64M 0.03% 638
2016
Q3
$26M Buy
368,635
+84,472
+30% +$6.32M 0.03% 720
2016
Q2
$21.5M Sell
284,163
-417,125
-59% -$30.7M 0.02% 731
2016
Q1
$48.2M Buy
701,288
+226,666
+48% +$16.3M 0.06% 317
2015
Q4
$41.5M Sell
474,622
-372,502
-44% -$31.9M 0.05% 476
2015
Q3
$68.6M Buy
847,124
+532,175
+169% +$46.4M 0.07% 306
2015
Q2
$28M Sell
314,949
-39,941
-11% -$3.49M 0.02% 803
2015
Q1
$30.8M Buy
354,890
+304,773
+608% +$25.6M 0.03% 736
2014
Q4
$4.24M Sell
50,117
-148,547
-75% -$11.6M ﹤0.01% 2131
2014
Q3
$14M Buy
198,664
+12,092
+6% +$861K 0.01% 1141
2014
Q2
$12.9M Buy
186,572
+51,827
+38% +$3.65M 0.01% 1081
2014
Q1
$10.1M Buy
134,745
+122,779
+1,026% +$9.19M 0.01% 1257
2013
Q4
$840K Sell
11,966
-49,141
-80% -$3.21M ﹤0.01% 3397
2013
Q3
$3.77M Sell
61,107
-234,462
-79% -$15.2M 0.01% 1814
2013
Q2
$18.2M Buy
+295,569
New +$17.8M 0.03% 706

Other funds holding ESRX

Citadel Advisors's ESRX Position: Q4 2018 in Review

Citadel Advisors sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 2,823,272 shares — an estimated $268M sold.

Citadel Advisors first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $268M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Citadel Advisors reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Citadel Advisors sold 2,823,272 Express Scripts Holding Company shares in Q4 2018, an estimated $268M.
  • Citadel Advisors first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
  • Citadel Advisors's Express Scripts Holding Company position peaked at $268M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.